W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL
|
Back to Search Results |
|
Catalog Number BXA083902A |
Device Problem
Migration (4003)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 06/19/2023 |
Event Type
malfunction
|
Event Description
|
On (b)(6), 2023, a study patient underwent endovascular treatment of a thoracoabdominal aortic aneurysm using a gore® excluder® thoracoabdominal branch endoprosthesis (tambe) in the aaa1701 tambe pivotal study.During this treatment, multiple gore® viabahn® vbx balloon expandable endoprosthesis (vbx device(s)) were implanted as side branch devices.The vbx devices were implanted in superior mesenteric artery (sma; 2), left renal artery (3), celiac artery (1) and right renal artery (4).On (b)(6), 2023, cta imaging was performed.Results showed a vbx device that had been implanted in the right renal artery as a distal extension within the portal was found in the aneurysm sac.The report stated the fourth right renal artery side branch component is present, fully deployed, within the aneurysm sac and is not connected to any additional components of the tambe system of devices.It follows the left renal artery side branch component and continues approximately 2cm distal of the left renal artery.Intervention, was not reported and patient appears to be asymptomatic.
|
|
Manufacturer Narrative
|
Cbas® heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.H6: code: c19: a review of the manufacturing records indicated the device met pre-release specifications.H3: and h6: code: b20: device remains implanted; therefore, direct product analysis was not possible.Images were not made available, but migration was confirmed by third party lab.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Search Alerts/Recalls
|
|
|